Sleep, Chronic Pain, and Fatigue in Rheumatic Disorders

Therapy in Sleep Medicine

Volumn , Issue , 2012, Pages 595-606

  Thirlwell, Celeste ^a   Moldofsky, Harvey ^a  

^a Centre for Sleep and Chronobiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882752036     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1703-7.10047-7     Document Type: Chapter

References (182)

1. National Institutes of Health, U.S. Department of Health and Human Services National Institute of Arthritis and Musculoskeletal and Skin Diseases, Available at. http://www.niams.nih.gov/.
2. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. J Joint Bone Spine 2008, 7:397-402.
3. Changani B.S., Roehrs T.A., Harris E.J., et al. Pain sensitivity in sleepy pain-free normals. Sleep 2009, 32:1011-1017.
4. Smith M.T., Edwards R.R., McCann U.D., Haythornthwaite J.A. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007, 30:494-505.
5. Silva A., Andersen M.L., Tufik S. Sleep patterns in an experimental model of osteoarthritis. Pain 2008, 140:446-456.
6. Nascimento D.C., Andersen M.L., Hipolide J.N., et al. Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to the brain mu-opioid receptors. Behav Brain Res 2007, 178:216-220.
7. Wei H., Ma A., Wang Y.X., Pertovaara A. Role of spinal 5-HT receptors in cutaneous hypersensitivity induced by REM sleep deprivation. Pharmacol Res 2008, 57:469-475.
8. Moldofsky H. Rheumatic manifestations of sleep disorders. Curr Opin Rheumatol 2010, 22:59-63.
9. Moldofsky H. The contribution of sleep medicine to the assessment of the tired patient. Can J Psychiatry 2000, 45:798-802.
10. Tirunahari V.L., Zaidi S.A., Sharma R., et al. Microsleep and sleepiness: A comparison of multiple sleep latency test and scoring of microsleep as a diagnostic test for excessive daytime sleepiness. Sleep Med 2003, 4:63-67.
11. Blaivas A.J., Patel R., Hom D., et al. Quantifying microsleep to help assess subjective sleepiness. Sleep Med 2007, 8:156-159.
12. Harrison Y., Horne J.A. Occurrence of "microsleeps" during daytime sleep onset in normal subjects. Electroencephalog Clin Neurophysiol 1996, 98:411-416.
13. Vaughn B.V., D'Cruz O.F. Cardinal manifestations of sleep disorders. Principles and Practice of Sleep Medicine 2005, 594-601. Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
14. Drake C., Roehrs T., Breslau N., et al. The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep 2010, 33:745-752.
15. Moldofsky H., MacFarlane J.G. Fibromyalgia and chronic fatigue syndromes. Principles and Practice of Sleep Medicine 2005, 1225-1236. Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
16. Smets E.M., Garseen B., Bonke B., et al. The Multidimensional Fatigue Inventory (MFI): Psychometric qualities of an instrument to assess fatigue. J Psychosomat Res 1995, 39:315-325.
17. Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J Psychosomat Med 1993, 37:147-153.
18. Krupp L.B., LaRocca N.G., Muir-Nash J., et al. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123.
19. Hoddes E., Zarcone V., Smythe H., et al. Quantification of sleepiness: A new approach. Psychophysiology 1973, 10:431-436.
20. John M.W. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991, 14:540-545.
21. Terzano M.G., Parino L., Sherieri A., et al. Consensus report: Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med 2002, 3:187-199.
22. MacFarlane J.G., Shahal B., Moldofsky H. Periodic K-alpha sleep EEG activity and periodic leg movements during sleep: Comparisons of clinical features and sleep parameters. Sleep 1996, 19:200-204.
23. Rizzi M., Sarzi-Puttini P., Atzeni F., et al. Cyclic alternating pattern: A new marker of sleep alteration in patients with fibromyalgia. J Rheumatol 2004, 31:1193-1199.
24. Benca R., Moldofsky H., Ancoli-Israel S. Special considerations in insomnia diagnosis and management: Depressed, elderly, and chronic pain populations. J Clin Psychiatry 2004, 65:26-35.
25. Moldofsky H., Scarisbrick P., England R., et al. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosomat Med 1975, 37:341-351.
26. Anch A.M., Lue F.A., Maclean A.W., et al. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. Can J Psychol 1991, 45:178-184.
27. MacFarlane J., Shahal B., Moldofsky H. Periodic K-alpha sleep EEG activity and periodic leg movements during sleep: Comparisons of clinical features and sleep parameters. Sleep 1996, 19:200-204.
28. Moldofsky H., Lue F.A., Smythe H.A. Alpha EEG sleep and morning symptoms in rheumatic arthritis. J Rheumatol 1983, 10:373-379.
29. Mahowald M.W., Mahowald M.L., Bundie S.R., Ytterberg S.R. Sleep fragmentation in rheumatoid arthritis. Arthritis Rheum 1989, 32:974-983.
30. Crosby L.J. Factors which contribute to fatigue associated with rheumatoid arthritis. J Adv Nurs 1991, 16:974-981.
31. Gudbjornsson B., Broman J.E., Hetta J., Hallgren R. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol 1993, 32:1072-1076.
32. Valencia-Flores M., Resendiz M., Castano V.A., et al. Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum 1999, 42:2189-2193.
33. Iaboni A., Gladman D.D., Urowitz M.B., Moldofsky H. Disordered sleep, sleepiness, and depression in chronically tired patients with systemic lupus erythematosus. Sleep 2004, 27:A327-A328.
34. Disdier P., Genton P., Harle J.R., et al. Fibromyalgia and narcolepsy. J Rheumatol 1993, 20:888-889.
35. Disdier P., Genton P., Bolla G., et al. Clinical screening for narcolepsy/cataplexy in patients with fibromyalgia. Clin Rheumatol 1994, 13:132-134.
36. Sarzi-Puttini P., Rizzi M., Andreoli A., et al. Hypersomnolence in fibromyalgia syndrome. Clin Exp Rheumatol 2002, 20:69-72.
37. Moldofsky H., Dickstein J., Luk W- P. Sleep, health and immunocompetence. New Foundation of Biology (Neuroimmune Biology, vol. 1) 2001, 255-268. Elsevier Science BV, Amsterdam. I. Berczi, I. Gorczynski (Eds.).
38. Kruger J.M. The role of cytokines in sleep regulation. Curr Pharm Des 2008, 14:3408-3416.
39. Schafers M., Sommer C., Geis C., et al. Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience 2008, 157:414-423.
40. Khairova R.A., Machado-Vieira R., Du J., Manji H.K. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 2009, 12:561-578.
41. Aletaha D., Landewe R., Karonitsch T., et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ARC collaborative recommendations. Arthritis Rheum 2008, 59:1371-1377.
42. Vgontzas A.N., Zoumakis E., Lin H.M., et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004, 89:4409-4413.
43. Wolfe F., Michaud K., Li T. Sleep disturbance in patients with rheumatoid arthritis: Evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol 2006, 33:1942-1951.
44. Genovese M.C., Schiff M., Luggen M., et al. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to antitumour necrosis factor therapy. Ann Rheum Dis 2008, 67:547-554.
45. Wells G., Li T., Maxwell L., et al. Responsiveness of patient record outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008, 67:260-265.
46. Yount S., Sorensen M.V., Cella D., et al. Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis. Clin Exp Rheumatol 2007, 25:838-846.
47. Zamarron C., Maceiras F., Mera A., Gomez-Reino J.J. Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann Rheum Dis 2004, 63:88-90.
48. Iaboni A., Moldofsky H. Sleep and medical disorders. Sleep Medicine (Cambridge Clinical Guides) 2008, 186-207. Cambridge University Press, Cambridge, United Kingdom. H.R. Smith, C.L. Comella, B. Hogl (Eds.).
49. Winfield J.B. Psychological determinants of fibromyalgia and related syndromes. Curr Rev Pain 2000, 4:276-286.
50. Hamilton N.A., Affleck G., Tennen H., et al. Fibromyalgia: The role of sleep in affect and in negative event reactivity and recovery. Health Psychol 2008, 27:490-497.
51. Bigatti S.M., Hernandez A.M., Cronan T.A., Rand K.L. Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Care Res 2008, 59:951-967.
52. Nicassio P.M., Wallston K.A. Longitudinal relationships among pain, sleep problems, and depression in rheumatoid arthritis. J Abnorm Psychol 1992, 101:514-520.
53. Cakirbay H., Bilici M., Kavakci O., et al. Sleep quality and immune functions in rheumatoid arthritis patients with and without major depression. Int J Neurosci 2004, 114:245-256.
54. Valtysdottir S.T., Gudbjornsson Lindqvist U., et al. Anxiety and depression in patients with primary Sjogren's syndrome. J Rheumatol 2000, 27:165-169.
55. Cobb S. Contained hostility in rheumatoid arthritis. Arthritis Rheum 1959, 2:419-425.
56. Moos R.H. Personality factors associated with rheumatoid arthritis: A review. J Chron Dis 1964, 17:41-55.
57. Leigh T.J. Sleep in rheumatic patients. Scand J Rheumatol 1990, 19:5-9.
58. Van Houdenhove B., Egle U.T. Fibromyalgia: A stress disorder? Piecing the biopsychosocial puzzle together. Psychother Psychosom 2004, 73:267-275.
59. Turk D.C., Monarch E.S., Williams A.D. Psychological evaluation of patients diagnosed with fibromyalgia syndrome: A comprehensive approach. Rheum Dis Clin North Am 2002, 28:219-233.
60. Hopko D.R., Lejuez C.W., Ruggiero K.J., et al. Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clin Psychol Rev 2003, 23:699-717.
61. Lundahl B., Burke B.L. The effectiveness and applicability of motivational interviewing: A practice-friendly review of four meta-analyses. J Clin Psychol 2009, 65:1233-1245.
62. Thieme K., Flor H., Turk D.C. Psychological pain treatment in fibromyalgia syndrome: Efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther 2006, 8:R121.
63. Thieme K., Turk D.C., Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: Relationship to somatic and psychosocial variables. Psychosom Med 2004, 66:837-844.
64. Turk D.C., Monarch E.S., Williams A.D. Psychological evaluation of patients diagnosed with fibromyalgia syndrome: A comprehensive approach. Rheum Dis Clin North Am 2002, 28:219-233.
65. Carlson L.E., Garland S.N. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 2005, 12:278-285.
66. Rosenweig S., Greeson J.M., Reibel D.K., et al. Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home medication practice. J Psychosom Res 2010, 68:29-36.
67. Lush E., Salmon P., Floyd A., et al. Mindfulness meditation for symptom reduction in fibromyalgia: Psychophysiological correlates. J Clin Psychol Med Settings 2009, 16:200-207.
68. Tacon A.M., McComb J., Caldera Y., et al. Mindfulness meditation, anxiety reduction, and heart disease: A pilot study. Fam Commun Health 2003, 26:25-33.
69. Williams J.M., Russell I., Russell D. Mindfulness-based cognitive therapy: Further issues in current evidence and future research. J Consult Clin Psychol 2008, 76:524-529.
70. Sesin C.A., Bingham C.O. Remission in rheumatoid arthritis: Wishful thinking or clinical reality?. Semin Arthritis Rheum 2005, 35:185-196.
71. Aletaha D., Neogi T., Silman A.J., et al. 2010 Rheumatoid arthritis classification criteria. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 2010, 62:2569-2581.
72. Bourguignon C., Taibi D., Taylor A.G. Sleep disturbances, fatigue, depression, and heart rate variability in menopausal women with and without RA. Sleep 2005, 28:302.
73. Drewes A.M., Svendsen L., Taagholt S.J., et al. Sleep in rheumatoid arthritis: A comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol 1998, 37:71-81.
74. Hirsch M., Carlander B., Verge M., et al. Objective and subjective sleep disturbances in patients with rheumatoid arthritis: A reappraisal. Arthritis Rheum 1994, 37:41-49.
75. Walsh J.K., Muelbach M.J., Lauter S.A., et al. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. J Rheumatol 1996, 23:245-252.
76. Grob D. Principles of surgical treatment of cervical spine in rheumatoid arthritis. Euro Spine J 1993, 2:180-190.
77. Brasington R.D. Clinical features of rheumatoid arthritis. Rheumatology 2007, 763-771. Mosby Elsevier, Spain. 4th ed. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman (Eds.).
78. Turesson C., Matteson E.L. Extra-articular features of rheumatoid arthritis and systemic invovement. Rheumatology 2007, 773-783. Mosby Elsevier, Spain. 4th ed. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman (Eds.).
79. Hicks J.E., Joe G.O., Gerber L.H. Rehabilitation of the patient with inflammatory arthritis and connective-tissue disease. Physical Medicine and Rehabilitation: Principles and Practice 2005, 721-763. Lippincott Williams & Wilkins, Philadelphia. 4th ed. J.A. DeLisa, B.M. Gans, N.E. Walsh (Eds.).
80. Redlund-Johnell I. Upper airway obstruction in patients with rheumatoid arthritis and temporomandibular joint destruction. Scand J Rheumatol 1988, 17:273-279.
81. Drossaers-Bakker K.W., Hamburger H.L., Bongartz E.B., et al. Sleep apnoea caused by rheumatoid arthritis. Br J Rheumatol 1998, 37:889-894.
82. Alamondi O.S. Sleep-disordered breathing in patients with acquired retrognathia secondary to rheumatoid arthritis. Med Sci Monit 2006, 12:CR530-CR534.
83. Gyori M., Sandra S., Szakacs Z., Koves P. Restless legs syndrome in rheumatoid arthritis. Sleep 2004, 27:A302.
84. Zamir G., Press J., Tal A., Tarasiuk A. Sleep fragmentation in children with juvenile rheumatoid arthritis. J Rheumatol 1998, 25:1191-1197.
85. Lopes M.C., Guilleminault C., Rosa A., et al. Delta sleep instability in children with chronic arthritis. Braz J Med Biol Res 2008, 41:938-943.
86. Twilt M., Schulten A.J., Nicolaas P., et al. Facioskeletal changes in children with juvenile idiopathic arthritis. Ann Rheum Dis 2006, 65:823-825.
87. Bloom B.J., Owens J.A., McGuinn M., et al. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis. J Rheumatol 2002, 29:169-173.
88. Hultgren S., Broman J.E., Gudbjornsson B., et al. Sleep disturbances in outpatients with ankylosing spondylitis: A questionnaire study with gender implications. Scand J Rheumatol 2000, 29:365-369.
89. Jamieson A.H., Alford C.A., Bird H.A., et al. The effect of sleep and nocturnal movement on stiffness, pain and psychomotor performance in ankylosing spondylitis. Clin Exp Rheumatol 1995, 13:73-78.
90. Jones S.D., Koh W.H., Steiner A., et al. Fatigue in ankylosing spondylitis: Its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 1996, 23:487-490.
91. Maksymowych W.P. Etiology, pathogenesis and pathology of ankylosing spondylitis. Rheumatology 2007, 1115-1130. Mosby Elsevier, Spain. 4th ed. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman (Eds.).
92. Defalque R.J., Hyder M.L. Laryngeal mask airway in severe cervical ankylosis. Can J Anaesth 1997, 44:305-307.
93. Ortancil O., Sarikaya S., Sapmaz P., et al. The effect(s) of a six-week home-based exercise program on the respiratory muscle and functional status in ankylosing spondylitis. J Clin Rheum 2009, 15:68-70.
94. Solak O., Fidan F., Dunbar U., et al. The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rhem 2009, 48:433-435.
95. Stitik T.P., Foye P.M., Stskal D., et al. Osteoarthritis. Physical Medicine and Rehabilitation: Principles and Practice 2005, 765-786. Lippincott Williams & Wilkins, Philadelphia. 4th ed. J.A. DeLisa, B.M. Gans, N.E. Walsh (Eds.).
96. Mader R., Sarzi-Puttini P., Atzeni F. Extraspinal manifestations of diffuse idiopathic skeletal hypertosis. Rheumatology 2009, 48:1478-1481.
97. Moldofsky H., Lue F.A., Saskin P. Sleep and morning pain in primary osteoarthritis. J Rheum 1987, 14:124-128.
98. Moldofsky H. Sleep influences on regional and diffuse pain syndromes associated with osteoarthritis. Semin Arthritis Rheum 1989, 18:18-21.
99. Tench C.M., MMcCurdie I., White P.D., D'Cruz D.P. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 2000, 39:1249-1254.
100. Wolfe F., Petri M., Alarcon G.S., et al. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity. J Rheumatol 2009, 36:82-88.
101. Prado G.F., Allen R.P., Trevisani V.M., et al. Sleep disruption in systemic sclerosis (scleroderma) patients: Clinical and polysomnographic findings. Sleep Med 2002, 3:341-345.
102. Antonioli C.M., Bua G., Frige A., et al. An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheum 2009, 28:159-165.
103. Hamuryudan V., Mat C., Saip S., et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998, 128:443-450.
104. Yamada M., Kashiwamura K., Nakamura Y., et al. On psychiatric symptoms of neuro-Behcet's syndrome. Folia Psychiatr Neurol Jpn 1978, 32:191-197.
105. Sakurai N., Koike Y., Kaneoke Y., et al. Sleep apnea and palatal myoclonus in a patient with neuro-Behcet syndrome. Intern Med 1993, 32:336-339.
106. Tishler M., Barak Y., Paran D., Yaron M. Sleep disturbances, fibromyalgia and primary Sjogren's syndrome. Clin Exp Rheumatol 1997, 15:71-74.
107. Servan J., Marchand F., Garma L., et al. Narcolepsy disclosing neurosarchoidosis. Rev Neurol (Paris) 1995, 151:281-283.
108. Turner G.A., Lower E.E., Corser B.C., et al. Sleep apnea in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997, 14:61-64.
109. Verbraecken J., Hoitsma E., van der Grinten C.P., et al. Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004, 21:137-146.
110. Clauw D.J. Fibromyalgia. Rheumatology 2007, 701-711. Mosby Elsevier, Spain. 4th ed. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman (Eds.).
111. Yunus M.B. A comprehensive medical evaluation of patients with fibromyalgia syndrome. Rheum Dis Clin North Am 2002, 28:201-217.
112. Arnold L.M., Hudson J.I., Keck P.E., et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006, 76:1219-1225.
113. Buskila D., Cohen H. Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep 2007, 11:333-338.
114. Hauser W., Thieme K., Turk D.C. Guidelines on the management of fibromyalgia syndrome-A systematic review. Euro J Pain 2010, 14:5-10.
115. Arnold L.M. Strategies for managing fibromyalgia. Am J Med 2009, 122:S31-S43.
116. Wolfe F., Cathey M.A., Kleinheksel S.M. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 1984, 11:814-818.
117. Buskila D., Press J., Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: Prevalence and clinical implications. Clin Rev Allergy Immunol 2003, 25:25-28.
118. Thompson M.E., Barkhuizen A. Fibromyalgia, hepatitis C infection and the cytokine connection. Curr Pain Headache Rep 2003, 7:342-347.
119. Golding D.N. Hypothyroidism presenting with musculoskeletal symptoms. Ann Rheum Dis 1970, 29:10-14.
120. Bland J.H., Frymoyer J.W. Rheumatic syndromes of myxedema. N Engl J Med 1970, 282:1171-1174.
121. Yunus M.B. Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007, 36:339-356.
122. Bested A.C., Logan A.C., Howe R. Chronic fatigue syndrome and fibromyalgia. Nashville. Cumberland House Pub 2006, 1-254.
123. Paiva E.S., Deodhar A., Jones K.D., et al. Impaired growth hormone secretion in fibromyalgia patients: Evidence for augmented hypothalamic somatostatin. Arthritis Rheum 2002, 46:440-450.
124. Demitrack M.A., Crofford L.J. Evidence for and pathophysiologic implications of the hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998, 840:684-697.
125. Klerman E.B., Goldenberg D.L., Brown E.N., et al. Circadian rhythms of women with fibromyalgia. J Clin Endocrin Metab 2001, 86:1034-1039.
126. Pillemer S.R., Bradley L.A., Crofford L.J., et al. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997, 40:1928-1939.
127. Onen S.H., Alloui A., Gross A., et al. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001, 10:35-42.
128. Lentz M.J., Landis C.A., Rothermel J., et al. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999, 26:1586-1592.
129. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
130. Turk D.C., Vierck C.J., Scarbrough E., et al. Fibromyalgia: Combining pharmacological and nonpharmacological approaches to treating the person, not just the pain. J Pain 2008, 9:99-104.
131. Clauw D.J. Fibromyalgia: Update on mechanisms and management. J Clin Rheumatol 2007, 13:102-109.
132. Wolfe F., Clauw D.J., Fitzcharles M.A., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010, 62:600-610.
133. Moldofsky H., MacFarlane J.G. Fibromyalgia and chronic fatigue syndromes. Principles and Practice of Sleep Medicine 2005, 1225-1236. Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
134. Stehlik R., Arvidsson L., Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. Euro Neurol 2009, 61:107-111.
135. Moldofsky H., Inhaber N.H., Guinta D.R., Alvarez-Horine S.B. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: A double-blind, randomized, placebo-controlled study. J Rheumatol 2010, 37(10):2156-2166.
136. Branco J., Atalaia A., Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 1994, 21:1113-1117.
137. Drewes A.M., Nielsen K.D., Taagholt S.J., et al. Sleep intensity in fibromyalgia: Focus on the microstructure of the sleep process. Br J Rheumatol 1995, 34:629-635.
138. Ware J.C., Russell I.J., Campos E. Alpha intrusions into the sleep of depression and fibromyalgia syndrome (fibrositis) patients (abstract). Sleep Res 1986, 15:210.
139. Roizenblatt S., Moldofsky H., Benedito-Silva A.A., Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001, 44:222-230.
140. Shaver J.L., Lentz M., Landis C.A., et al. Sleep, psychological distress, and stress arousal in women with fibromyalgia. Res Nurs Health 1997, 20:247-257.
141. Wittig R.M., Zorick F.J., Blumer D., et al. Disturbed sleep in patients complaining of chronic pain. J Nerv Ment Dis 1982, 70:429-431.
142. Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia. Rheum Dis Clin North Am 2009, 35:275-283.
143. Staud R. Pharmacological treatment of fibromyalgia syndrome: New developments. Drugs 2010, 70:1-4.
144. Scharf M.B., Baumann M., Berkowitz D.V. The effect of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003, 30:1070-1074.
145. Russell I.J., Bennett R.M., Michalek J.E. Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009, 60:299-309.
146. Holdcraft L.C., Assefi N., Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003, 17:667-683.
147. Haanen H.C., Hoenderdos H.T., Van Romunde L.K., et al. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1987, 14:820-825.
148. Ferraccioli G., Ghirelli L., Scita F., et al. EMG biofeedback training in fibromyalgia syndrome. J Rheumatol 1987, 14:820-825.
149. Oliver K., Cronan T.A., Walen H.R., et al. Effects of social support and education on health care costs for patients with fibromyalgia. J Rheumatol 2001, 28:2711-2719.
150. Burckhardt C.S., Mannerkorpi K., Hedenberg L., et al. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994, 21:714-720.
151. Rooks D.S., Gautam S., Romelig M., et al. Group exercise, education, and combination self-management in women with fibromyalgia: A randomized trial. Arch Intern Med 2007, 167:2192-2200.
152. Busch A.J., Barber K.A., Overend T.J., et al. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2007, 4:CD003786.
153. da Silva G.D., Lorenzi-Filho G., Lage L.V., et al. Effects of yoga and the addition of tui na in patients with fibromyalgia. J Altern Complement Med 2007, 13:1107-1113.
154. Taggart H.M., Arslanian C.L., Bae S., et al. Effects of tai chi exercise on fibromyalgia symptoms and health-related quality of life. Orthop Nurs 2003, 30:2257-2262.
155. Mayhew E., Ernst E. Acupuncture for fibromyalgia-A systemic review of randomized clinical trials. Rheumatology (Oxford) 2007, 46:801-804.
156. Deluze C., Bosia L., Zirbs A., et al. Electroacupuncture in fibromyalgia: Results of a controlled trial. BMJ 1992, 14:820-825.
157. Almeida T.F., Roizenblatt S., Benedito-Silva A.A., et al. The effects of combined therapy (ultrasound and interferential current) on pain and sleep in fibromyalgia. Pain 2003, 104:665-672.
158. Jungquist C.R., O'Brien C., Matteson-Rusby S., Smith M.T., et al. The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain. Sleep Med 2010, 11:302-309.
159. Krystal A.D., Edinger J.D. Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia. Sleep 2010, 33:669-677.
160. Carskadon M.A., Dement W.C. Normal human sleep: An overview. Principles and Practice of Sleep Medicine 2005, 13-23. Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
161. Walker J.M., Farney R.J., Rhondeau S.M., et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic beathing. J Clin Sleep Med 2007, 3:455-461.
162. Alaltar M.A., Scarf S.M. Opioid-associated central sleep apnea: A case series. Sleep Breath 2009, 13:201-206.
163. Sweitzer P.K. Drugs that disturb sleep and wakefulness. Principles and Practices of Sleep Medicine 2000, 441-461. Saunders, Philadelphia. 3rd ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
164. Gillin J.C. The long and the short of sleeping pills. N Engl J Med 1991, 324:1735-1736.
165. Guilleminault C. Benzodiazepines, breathing and sleep. Am J Med 1990, 88:25S-28S.
166. Drewes A.M., Andreasen A., Jennum P., et al. Zopiclone in the treatment of sleep abnormalitites in fibromyalgis. Scand J Rheumatol 1991, 20:288-293.
167. Moldofsky H., Lue F.A., Mously C., et al. The effect of zolpidem in patients with fibromyalgia: A dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1966, 23:529-533.
168. Eisen J., Macfarlane J., Shapiro C.M. Psychotropic drugs and sleep. ABC of sleep disorders. BMJ 1993, 306:1331-1334.
169. Moldofsky H., Lue F.A. The relationship of alpha and delta EEG frequencies to pain and mood in "fibrositis" patients treated with chlorpromazine and L-tryptophan. Electroencephalogr Clin Neurophysiol 1980, 50:71-80.
170. Sammaritano M., Sherwin A. Effects of anticonvulsants on sleep. Neurology 2000, 54:S16-S24.
171. Scweitzer P.K. Drugs that disturb sleep and wakefulness. Principles and Practice of Sleep Medicine 2005, 499-518. Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
172. Yang C., White D.P., Winkelman J.W. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005, 58:510-514.
173. Nader P, Coralie L, Baleydier B, et al. Restless legs syndrome induced by citalopram: A psychiatric emergency? Gen Hosp Psychiatry. 3007;29:72-74.
174. Goldenberg D., Mayskiy M., Mossey C., et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996, 39:1852-1859.
175. Nofzinger E.A., Fasiczka A., Berman S., et al. Buproprion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 2000, 61:858-862.
176. Branco J.C., Martini A., Palva T. Treatment of sleep abnormalities and clinical complaints in fibromyalgia with trazadone (abstract). Arthritis Rheum 1996, 39:591.
177. Kim S.W., Shin I.S., Kim J.M., et al. Factors potentiating the risk of mirtazapine-associated restless legs syndrome. Hum Psychopharmacol 2008, 23:615-620.
178. Bennett R.M., Gatter R.A., Campbell S.M., et al. A comparison of cyclobenzaprine and placebo in the management of fibrositis: A double blind controlled study. Arthritis Rheum 1988, 3:1535-1542.
179. Carette S., Bell M.V., Reynolds W.J., et al. Comparison of amitriptyline, cyclobenzaprine and placebo in the treatment of fibromyalgia: A randomized double blind clinical trial. Arthritis Rheum 1994, 37:32-40.
180. Reynolds W.J., Moldofsky H., Saskin P., et al. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991, 18:452-454.
181. Carette S., Oakson G., Guimont C., et al. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995, 38:1211-1217.
182. Abad V.C., Sarinas P.S.A., Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 2008, 12:211-228.